Literature DB >> 20333547

Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.

Lan Wang1, Guifen He, Pingzhao Zhang, Xiang Wang, Mei Jiang, Long Yu.   

Abstract

MDM2, Pirh2 and COP1 are important E3 ubiquitin ligases, which directly interact with p53 and target p53 for proteasome-mediated degradation. MDMX, the MDM2 homologous protein, inhibits p53-mediated transcription activity. The interplay between MDM2, MDMX, Pirh2 and COP1 has not been reported, except the interaction between MDM2 and MDMX. Here, we reported that there were interactions between these four proteins independently of p53. The protein levels of MDM2, MDMX, Pirh2 and COP1 changed when any two of them were co-transfected. Our data also showed that the integrity of MDM2 RING finger domain was crucial for its ability to elevate the protein levels of COP1 and Pirh2. Any two of these four proteins could inhibit p53-mediated transcriptional activity synergistically. Furthermore, COP1 inhibited MDM2 self-ubiquitination and interfered with MDMX ubiquitination by MDM2. Our results suggest that MDM2, MDMX, Pirh2 and COP1 might inhibit p53 activity synergistically in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20333547     DOI: 10.1007/s11033-010-0099-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  32 in total

1.  Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.

Authors:  S Fang; J P Jensen; R L Ludwig; K H Vousden; A M Weissman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

2.  Regulation of MDMX expression by mitogenic signaling.

Authors:  Daniele M Gilkes; Yu Pan; Domenico Coppola; Timothy Yeatman; Gary W Reuther; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2008-01-02       Impact factor: 4.272

3.  p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2.

Authors:  Lingling Xian; Jing Zhao; Jia Wang; Zhou Fang; Bo Peng; Wenzhang Wang; Xiaona Ji; Long Yu
Journal:  Mol Biol Rep       Date:  2009-10-16       Impact factor: 2.316

4.  MDMX: a novel p53-binding protein with some functional properties of MDM2.

Authors:  A Shvarts; W T Steegenga; N Riteco; T van Laar; P Dekker; M Bazuine; R C van Ham; W van der Houven van Oordt; G Hateboer; A J van der Eb; A G Jochemsen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

Review 5.  Mdmx and Mdm2: brothers in arms?

Authors:  Jean-Christophe Marine; Aart G Jochemsen
Journal:  Cell Cycle       Date:  2004-07-02       Impact factor: 4.534

6.  MDM2 promotes ubiquitination and degradation of MDMX.

Authors:  Yu Pan; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

7.  PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.

Authors:  Gang Zheng; Jinying Ning; Yu-Chung Yang
Journal:  Biochem Biophys Res Commun       Date:  2007-10-11       Impact factor: 3.575

8.  The ubiquitin ligase COP1 is a critical negative regulator of p53.

Authors:  David Dornan; Ingrid Wertz; Harumi Shimizu; David Arnott; Gretchen D Frantz; Patrick Dowd; Karen O'Rourke; Hartmut Koeppen; Vishva M Dixit
Journal:  Nature       Date:  2004-04-21       Impact factor: 49.962

9.  Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2.

Authors:  Petra de Graaf; Natalie A Little; Yolande F M Ramos; Erik Meulmeester; Stef J F Letteboer; Aart G Jochemsen
Journal:  J Biol Chem       Date:  2003-07-21       Impact factor: 5.157

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  25 in total

Review 1.  Role of E3 ubiquitin ligases in gastric cancer.

Authors:  Ya-Chao Hou; Jing-Yu Deng
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

2.  Association of p73 G4C14-to-A4T14 polymorphism with lung cancer risk.

Authors:  Hua Liu; Yuli Liang; Hua Liao; Lanying Li; Hongyun Wang
Journal:  Tumour Biol       Date:  2014-06-19

3.  Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk.

Authors:  Lan Wang; Rui Gao; Long Yu
Journal:  Mol Biol Rep       Date:  2011-05-27       Impact factor: 2.316

Review 4.  Role of p53 in neurodegenerative diseases.

Authors:  J Robert Chang; Mohammad Ghafouri; Ruma Mukerjee; Asen Bagashev; Tinatin Chabrashvili; Bassel E Sawaya
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

5.  The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.

Authors:  Shenshan Zou; Yufu Zhu; Bin Wang; Fengyuan Qian; Xiang Zhang; Lei Wang; Chunling Fu; Hanmo Bao; Manyi Xie; Shangfeng Gao; Rutong Yu; Hengliang Shi
Journal:  Mol Neurobiol       Date:  2016-08-17       Impact factor: 5.590

6.  Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells.

Authors:  Glenda N da Silva; Adriane F Evangelista; Danielle A Magalhães; Cláudia Macedo; Michelle C Búfalo; Elza T Sakamoto-Hojo; Geraldo A S Passos; Daisy M F Salvadori
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

7.  PNAS-4 expression and its relationship to p53 in colorectal cancer.

Authors:  Bin Zhou; Hui Yan; Yuan Li; Rong Wang; Keling Chen; Zongguang Zhou; Xiaofeng Sun
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

8.  Pirh2 E3 ubiquitin ligase monoubiquitinates DNA polymerase eta to suppress translesion DNA synthesis.

Authors:  Yong-Sam Jung; Anne Hakem; Razqallah Hakem; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2011-07-26       Impact factor: 4.272

9.  TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Jing-Jun Wang; Yuan Zheng; Liang Sun; Li Wang; Peng-Bo Yu; Jian-Hua Dong; Lei Zhang; Jing Xu; Wei Shi; Yu-Chun Ren
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

10.  Ubiquitylation of p53 by the APC/C inhibitor Trim39.

Authors:  Liguo Zhang; Nai-Jia Huang; Chen Chen; Wanli Tang; Sally Kornbluth
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.